和铂医药-B(02142.HK)10月23日耗资247万港元回购20万股

Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) announced a share buyback of 200,000 shares at a cost of HKD 2.47 million on October 23 [1] Group 1 - The company executed a buyback program, indicating confidence in its stock value [1] - The total expenditure for the buyback was HKD 2.47 million [1] - The number of shares repurchased was 200,000 [1]